← All indications
Shock, Cardiogenic
Shock resulting from diminution of cardiac output in heart disease.
Drugs by status
Approved for this indication (1)
Phase 4 trials (17)
Phase 3 trials (6)
Phase 2 trials (6)
Phase 1 trials (1)
Other trials (5)
Organizations
Organization Involved with Phase 4 Indications (15)
- Amgen
- Eli Lilly
- Teaching Hospital Královské Vinohrady (FNKV)
- Loyola University
- Osaka University
- University of Milan
- University of Oslo
- University of Ottawa
- Capital Medical University
- Zhengzhou University
- University of Limoges
- Charles University
- University of Lorraine
- The Cleveland Clinic
- Hospital Universitario Ramon y Cajal
Organization Involved with Phase 3 Indications (7)
Organization Involved with Phase 2 Indications (6)
Organization Involved with Other Experimental Indications (1)